Safety profile and efficacy of botulinum toxin A (dysport) in children with muscle spasticity (vol 43, pg 234, 2001)

被引：0
|
作者：
Bakheit, AMO
Severa, S
Cosgrove, A
Morton, R
Roussounis, SH
Doderlein, L
Lin, JP
机构：
来源：
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY | 2001年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study
    Juan F. Vázquez-Costa
    Inmaculada Máñez
    Ana Alabajos
    Maricruz Guevara Salazar
    Cristina Roda
    Teresa Sevilla
    Journal of Neurology, 2016, 263 : 1954 - 1960
  • [22] Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy (vol 136, pg 895, 2015)
    Edwards, P.
    Sakzewski, L.
    Copeland, L.
    PEDIATRICS, 2016, 138 (03)
  • [23] Efficacy and Safety of AbobotulinumtoxinA (Dysport®) in Children with Dynamic Equinus Foot Deformity Previously Treated with Botulinum Toxins
    Dabrowski, D.
    Bonikowski, M.
    Gormley, M.
    Grandoulier, A.
    Picaut, P.
    Delgado, M.
    ANNALS OF NEUROLOGY, 2016, 80 : S367 - S367
  • [24] Efficacy and safety of abobotulinumtoxinA (Dysport®) in children with dynamic equinus foot deformity previously treated with botulinum toxins
    Dabrowski, Edward
    Bonikowski, Marcin
    Gormley, Mark
    Grandoulier, Anne-Sophie
    Picaut, Philippe
    Delgado, Mauricio
    NEUROLOGY, 2017, 88
  • [25] The profile of adult patients with upper limb muscle spasticity treated with botulinum toxin type A (an international survey)
    Khat'Kova, S. E.
    Timerbaeva, S. L.
    Orlova, O. R.
    Poznyakova, E. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (08) : 23 - 26
  • [26] Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment
    Alessio Baricich
    Alessandro Picelli
    Andrea Santamato
    Stefano Carda
    Alessandro de Sire
    Nicola Smania
    Carlo Cisari
    Marco Invernizzi
    Clinical Drug Investigation, 2018, 38 : 991 - 1000
  • [27] Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment
    Baricich, Alessio
    Picelli, Alessandro
    Santamato, Andrea
    Carda, Stefano
    de Sire, Alessandro
    Smania, Nicola
    Cisari, Carlo
    Invernizzi, Marco
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 991 - 1000
  • [28] Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders
    Garcia Ron, A.
    Miranda, M. C.
    Garriga Braun, C.
    Jensen Veron, J.
    Torrens Martinez, J.
    Diez Hanbino, M. P.
    ANALES DE PEDIATRIA, 2012, 77 (04): : 289 - 291
  • [29] Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy
    Colovic, Hristina
    Dimitrijevic, Lidija
    Stankovic, Ivona
    Nikolic, Dejan
    Radovic-Janosevic, Dragana
    BIOMEDICAL PAPERS-OLOMOUC, 2012, 156 (01): : 41 - 47
  • [30] Efficacy and safety of abobotulinumtoxinA (Dysport®) in children with dynamic equinus foot deformity previously treated with botulinum toxins
    Dabrowski, Edward
    Bonikowski, Marcin
    Gormley, Mark
    Grandoulier, Anne-Sophie
    Picaut, Philippe
    Delgado, Mauricio
    NEUROLOGY, 2017, 88
12345